Back to News & Stories
PxWire Volume 16, Issue No. 1
Check out the latest issue of PxWire here! And see key highlights below:
- Between the period January-September 2024 to January-September 2025, PrEP initiations fell between 13% and 66% in selected high-volume PrEP countries.
- The timeline for hitting key milestones in product introduction is moving faster for injectable LEN than for any previous PrEP products.
- LEN’s accelerated timeline compared to oral PrEP, DVR, and CAB reflects a field-wide effort to learn lessons from previous PrEP rollout and not repeat the mistakes of the past.
- Despite the challenges posed for research in 2025, and HIV research in particular, two notable vaccine trials launched at the start of 2026.